Annual Current Liabilities
$1.97 M
-$28.80 K-1.44%
June 30, 2024
Summary
- As of February 7, 2025, INM annual total current liabilities is $1.97 million, with the most recent change of -$28.80 thousand (-1.44%) on June 30, 2024.
- During the last 3 years, INM annual current liabilities has fallen by -$243.60 thousand (-11.00%).
- INM annual current liabilities is now -40.60% below its all-time high of $3.32 million, reached on June 30, 2022.
Performance
INM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$1.44 M
-$535.90 K-27.18%
September 30, 2024
Summary
- As of February 7, 2025, INM quarterly total current liabilities is $1.44 million, with the most recent change of -$535.90 thousand (-27.18%) on September 30, 2024.
- Over the past year, INM quarterly current liabilities has dropped by -$92.90 thousand (-6.08%).
- INM quarterly current liabilities is now -68.91% below its all-time high of $4.62 million, reached on December 31, 2021.
Performance
INM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
INM Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.4% | -6.1% |
| 3 y3 years | -11.0% | -56.7% |
| 5 y5 years | +65.6% | -33.3% |
INM Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.6% | at low | -68.9% | +7.2% |
| 5 y | 5-year | -40.6% | +65.6% | -68.9% | +13.2% |
| alltime | all time | -40.6% | +4321.1% | -68.9% | >+9999.0% |
InMed Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.44 M(-27.2%) |
| Jun 2024 | $1.97 M(-1.4%) | $1.97 M(+29.0%) |
| Mar 2024 | - | $1.53 M(-9.0%) |
| Dec 2023 | - | $1.68 M(+25.5%) |
| Sep 2023 | - | $1.34 M(-33.1%) |
| Jun 2023 | $2.00 M(-39.7%) | $2.00 M(-11.9%) |
| Mar 2023 | - | $2.27 M(-5.5%) |
| Dec 2022 | - | $2.40 M(-26.9%) |
| Sep 2022 | - | $3.28 M(-1.1%) |
| Jun 2022 | $3.32 M(+49.8%) | $3.32 M(-19.1%) |
| Mar 2022 | - | $4.11 M(-11.1%) |
| Dec 2021 | - | $4.62 M(+139.6%) |
| Sep 2021 | - | $1.93 M(-13.0%) |
| Jun 2021 | $2.22 M(+32.2%) | $2.22 M(+29.2%) |
| Mar 2021 | - | $1.71 M(-20.4%) |
| Dec 2020 | - | $2.15 M(+14.9%) |
| Sep 2020 | - | $1.87 M(+11.8%) |
| Jun 2020 | $1.68 M(+40.8%) | $1.68 M(+21.8%) |
| Mar 2020 | - | $1.38 M(+8.5%) |
| Dec 2019 | - | $1.27 M(+14.9%) |
| Sep 2019 | - | $1.10 M(-7.2%) |
| Jun 2019 | $1.19 M(+67.0%) | $1.19 M(+138.1%) |
| Mar 2019 | - | $500.10 K(+23.8%) |
| Dec 2018 | - | $403.90 K(-11.6%) |
| Sep 2018 | - | $457.00 K(-35.9%) |
| Jun 2018 | $713.00 K(+150.9%) | $713.00 K(+44.7%) |
| Mar 2018 | - | $492.60 K(+108.9%) |
| Dec 2017 | - | $235.80 K(+54.3%) |
| Sep 2017 | - | $152.80 K(-46.2%) |
| Jun 2017 | $284.20 K(-37.7%) | $284.20 K(+14.9%) |
| Mar 2017 | - | $247.30 K(+62.9%) |
| Dec 2016 | - | $151.80 K(-51.9%) |
| Sep 2016 | - | $315.50 K(-30.8%) |
| Jun 2016 | $456.20 K(+629.9%) | $456.20 K(-29.7%) |
| Mar 2016 | - | $649.00 K(+71.4%) |
| Dec 2015 | - | $378.70 K(+95.1%) |
| Sep 2015 | - | $194.10 K(+210.6%) |
| Jun 2015 | $62.50 K(-10.8%) | $62.50 K(-80.4%) |
| Mar 2015 | - | $318.80 K(-28.8%) |
| Dec 2014 | - | $447.70 K(+85.8%) |
| Sep 2014 | - | $240.90 K(+243.7%) |
| Jun 2014 | $70.10 K(+42.5%) | $70.10 K(-62.0%) |
| Mar 2014 | - | $184.70 K(+98.4%) |
| Dec 2013 | - | $93.10 K(+60.0%) |
| Sep 2013 | - | $58.20 K(+18.3%) |
| Jun 2013 | $49.20 K | $49.20 K(+49.5%) |
| Mar 2013 | - | $32.90 K(+35.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $24.30 K(-45.6%) |
| Sep 2012 | - | $44.70 K(+0.2%) |
| Jun 2012 | $44.60 K(-3.5%) | $44.60 K(+216.3%) |
| Mar 2012 | - | $14.10 K(+243.9%) |
| Dec 2011 | - | $4100.00(-91.2%) |
| Sep 2011 | - | $46.80 K(+1.3%) |
| Jun 2011 | $46.20 K(-96.4%) | $46.20 K(-89.7%) |
| Mar 2011 | - | $448.40 K(-67.4%) |
| Dec 2010 | - | $1.38 M(+3.0%) |
| Sep 2010 | - | $1.34 M(+4.6%) |
| Jun 2010 | $1.28 M(+21.2%) | $1.28 M(-13.1%) |
| Mar 2010 | - | $1.47 M(+9.4%) |
| Dec 2009 | - | $1.34 M(+9.0%) |
| Sep 2009 | - | $1.23 M(+16.9%) |
| Jun 2009 | $1.05 M(-29.5%) | $1.05 M(-14.4%) |
| Mar 2009 | - | $1.23 M(-0.1%) |
| Dec 2008 | - | $1.23 M(-14.5%) |
| Sep 2008 | - | $1.44 M(-3.6%) |
| Jun 2008 | $1.50 M(+13.9%) | $1.50 M(+18.7%) |
| Mar 2008 | - | $1.26 M(-9.0%) |
| Dec 2007 | - | $1.38 M(+23.9%) |
| Sep 2007 | - | $1.12 M(-14.9%) |
| Jun 2007 | $1.31 M(+19.6%) | $1.31 M(+22.0%) |
| Mar 2007 | - | $1.08 M(-5.1%) |
| Dec 2006 | - | $1.14 M(+54.5%) |
| Sep 2006 | - | $735.00 K(-33.1%) |
| Jun 2006 | $1.10 M(-29.3%) | $1.10 M(-17.2%) |
| Mar 2006 | - | $1.33 M(-0.4%) |
| Dec 2005 | - | $1.33 M(-20.2%) |
| Sep 2005 | - | $1.67 M(+7.4%) |
| Jun 2005 | $1.55 M(+105.7%) | $1.55 M(+1.8%) |
| Mar 2005 | - | $1.53 M(-52.4%) |
| Dec 2004 | - | $3.21 M(+307.4%) |
| Sep 2004 | - | $786.80 K(+4.2%) |
| Jul 2004 | $755.30 K(+61.0%) | $755.30 K(+20.5%) |
| Apr 2004 | - | $626.80 K(-25.3%) |
| Jan 2004 | - | $839.00 K(+9.3%) |
| Oct 2003 | - | $767.60 K(+63.7%) |
| Jul 2003 | $469.00 K(+530.4%) | $469.00 K(+757.4%) |
| Apr 2003 | - | $54.70 K(+6.6%) |
| Jan 2003 | - | $51.30 K(-2.3%) |
| Oct 2002 | - | $52.50 K(-29.4%) |
| Jul 2002 | $74.40 K(-84.9%) | $74.40 K(+1.2%) |
| Apr 2002 | - | $73.50 K(-57.2%) |
| Jan 2002 | - | $171.90 K(-11.8%) |
| Oct 2001 | - | $195.00 K |
| Jul 2001 | $493.00 K | - |
FAQ
- What is InMed Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual current liabilities year-on-year change?
- What is InMed Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly current liabilities year-on-year change?
What is InMed Pharmaceuticals annual total current liabilities?
The current annual current liabilities of INM is $1.97 M
What is the all time high annual current liabilities for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual total current liabilities is $3.32 M
What is InMed Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, INM annual total current liabilities has changed by -$28.80 K (-1.44%)
What is InMed Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of INM is $1.44 M
What is the all time high quarterly current liabilities for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly total current liabilities is $4.62 M
What is InMed Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, INM quarterly total current liabilities has changed by -$92.90 K (-6.08%)